[1]
Reina-Llompart, N. et al. 2025. [Erratum] Tofacitinib improves motor symptoms in parkinsonism associated with a heterozygous NGLY1 variant and autoimmune disease. European Journal of Case Reports in Internal Medicine. 12, 11 (Nov. 2025). DOI:https://doi.org/10.12890/2023_005975.